(Q35117090)

6 August 2017

1 reference

title

The therapeutic potential of lactoferrin (English)

1 reference

6 August 2017

Eugene D Weinberg

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Expert Opinion on Investigational Drugs

6 August 2017

published in

1 reference

6 August 2017

volume

12

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

841-851

1 reference

Human lactoferrin: a novel therapeutic with broad spectrum potential

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Iron, infection and sudden infant death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Expression of a human lactoferrin cDNA in tobacco cells produces antibacterial protein(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Expression of cloned human lactoferrin in baby-hamster kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Large scale production of recombinant human lactoferrin in the milk of transgenic cows

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Expression, characterization, and purification of recombinant porcine lactoferrin in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Killing of gram-negative bacteria by lactoferrin and lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

The effect of human lactoferrin on the MICs of doxycycline and rifampicin for Burkholderia cepacia and Pseudomonas aeruginosa strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

A component of innate immunity prevents bacterial biofilm development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Remarkable attachment of lactoferrin to Streptococcus pyogenes during acute pharyngotonsillitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Anti-invasive activity of bovine lactoferrin towards group A streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Lactoferrin, amylase and mucin MUC5B and their relation to the oral microflora in hyposalivation of different origins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Lactoferrin is responsible for the fungistatic effect of human milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Complete response of severe, refractory oral candidiasis to mouthwash containing lactoferrin and lysozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Endotoxin inactivation by enterally applied colostrum of different composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Lactoferrin in the preterm infants' diet attenuates iron-induced oxidation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Lactoferricin, a new antimicrobial peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Increased antibacterial activity of 15-residue murine lactoferricin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the inhibition of rotavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Enhanced antitumor activity and selectivity of lactoferrin-derived peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Antilactoferrin antibodies in autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Immobilized lactoferrin is a stimulus for eosinophil activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates rever

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Leishmania chagasi: uptake of iron bound to lactoferrin or transferrin requires an iron reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Human recombinant lactoferrin is ineffective in the treatment of human Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

Novel therapies for Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

A milk protein lactoferrin enhances human T cell leukemia virus type I and suppresses HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

The physiology of lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.5.841

10.1517/13543784.12.5.841

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference